ES2959184T3 - Composiciones y métodos para aumentar el rendimiento atlético - Google Patents

Composiciones y métodos para aumentar el rendimiento atlético Download PDF

Info

Publication number
ES2959184T3
ES2959184T3 ES16800834T ES16800834T ES2959184T3 ES 2959184 T3 ES2959184 T3 ES 2959184T3 ES 16800834 T ES16800834 T ES 16800834T ES 16800834 T ES16800834 T ES 16800834T ES 2959184 T3 ES2959184 T3 ES 2959184T3
Authority
ES
Spain
Prior art keywords
exercise
betalain
betalains
compositions
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16800834T
Other languages
English (en)
Spanish (es)
Inventor
Zbigniew Pietrzkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VDF FutureCeuticals
Original Assignee
VDF FutureCeuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VDF FutureCeuticals filed Critical VDF FutureCeuticals
Application granted granted Critical
Publication of ES2959184T3 publication Critical patent/ES2959184T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ES16800834T 2015-05-27 2016-05-27 Composiciones y métodos para aumentar el rendimiento atlético Active ES2959184T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562167229P 2015-05-27 2015-05-27
PCT/US2016/034802 WO2016191736A1 (en) 2015-05-27 2016-05-27 Compositions and methods for increasing athletic performance

Publications (1)

Publication Number Publication Date
ES2959184T3 true ES2959184T3 (es) 2024-02-21

Family

ID=57393796

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16800834T Active ES2959184T3 (es) 2015-05-27 2016-05-27 Composiciones y métodos para aumentar el rendimiento atlético

Country Status (9)

Country Link
US (3) US11446284B2 (enExample)
EP (2) EP3302512B1 (enExample)
JP (1) JP6833726B2 (enExample)
DK (1) DK3302512T3 (enExample)
ES (1) ES2959184T3 (enExample)
FI (1) FI3302512T3 (enExample)
PL (1) PL3302512T3 (enExample)
PT (1) PT3302512T (enExample)
WO (1) WO2016191736A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7095868B2 (ja) * 2018-07-30 2022-07-05 国立大学法人金沢大学 神経障害性疼痛の医薬組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027042A (en) 1974-10-15 1977-05-31 Wisconsin Alumni Research Foundation Color extract from beets and method for the preparation of same
GB1559275A (en) 1975-10-07 1980-01-16 Lafon Labor Process for the preparation of a stable beta vulgaris extrct
US4238518A (en) 1978-04-28 1980-12-09 Laboratoire L. Lafon Process for the preparation of a stable Beta vulgaris extract
US4409254A (en) 1980-09-29 1983-10-11 General Foods Corporation Process for concentrating and isolating a beet colorant
IL119872A (en) 1996-12-19 2000-01-31 Israel State Pharmaceutical compositions containing antioxidant betalains and a method for their preparation
US20030036565A1 (en) 2001-06-22 2003-02-20 Wisconsin Alumni Research Foundation Cancer chemopreventive agents
US8198512B2 (en) 2005-02-28 2012-06-12 Wisconsin Alumni Research Foundation High pigment golden beets
PL2114424T3 (pl) 2007-01-31 2021-08-16 Vdf Futureceuticals, Inc. Kompozycje i sposoby stałej betalainy
EP3159000B1 (en) 2007-02-26 2025-05-21 HeartBeet Ltd. Performance enhancing composition
WO2010014839A1 (en) 2008-07-30 2010-02-04 Vdf Futureceuticals, Inc. Betalain compositions and uses thereof
WO2012016018A1 (en) 2010-07-28 2012-02-02 Vdf Futureceuticals, Inc. Compositions and methods for improvement of oxygen metabolism and cytokine regulation
EP2420243A1 (en) 2010-08-18 2012-02-22 Inovativo Biomedicinas Tehnologiju Instituts, SIA Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming
TW201318566A (zh) 2011-11-01 2013-05-16 呂健民 膳食補充劑組合物及其用於調控血糖之方法
US20140087011A1 (en) 2012-05-16 2014-03-27 Louise M. Smith RyWhe / The Drink of Life
DE102014007762A1 (de) 2013-05-31 2014-12-04 Gabriele Pütz Kohlehydrat-Konzentrat, Verfahren zu seiner Herstellung und wässriges Getränkekonzentrat
US20160303176A1 (en) 2015-04-15 2016-10-20 Erroll J. Bailey Nutritional supplement
CN105285634B (zh) 2015-11-11 2017-12-01 浙江工商大学 一种运动训练提效型天然功能饮剂组合物及其应用

Also Published As

Publication number Publication date
PT3302512T (pt) 2023-10-13
EP4233877A3 (en) 2023-10-25
WO2016191736A1 (en) 2016-12-01
PL3302512T3 (pl) 2023-12-18
US20220387409A1 (en) 2022-12-08
JP2018515590A (ja) 2018-06-14
US11944610B2 (en) 2024-04-02
EP4233877A2 (en) 2023-08-30
EP3302512B1 (en) 2023-07-05
DK3302512T3 (da) 2023-10-09
EP3302512A4 (en) 2019-02-13
EP3302512A1 (en) 2018-04-11
US20180296544A1 (en) 2018-10-18
US20240226077A1 (en) 2024-07-11
US11446284B2 (en) 2022-09-20
JP6833726B2 (ja) 2021-02-24
FI3302512T3 (fi) 2023-10-04

Similar Documents

Publication Publication Date Title
ES2618655T3 (es) Composición que mejora el rendimiento y uso de la misma
US11241406B2 (en) Compositions and methods for acutley raising nitric oxide levels
CN103918965B (zh) 一种缓解体力疲劳的饮料
JP2010519336A (ja) 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
ES2837043T3 (es) Una composición que comprende un extracto de tomate para prevenir la inflamación del sistema inducida por el ejercicio
US11096409B2 (en) Compositions of nitrates and methods of use thereof
CN101646358B (zh) 含有a-酮酸的食品补充剂
Oh et al. Effect of supplementation with Ecklonia cava polyphenol on endurance performance of college students
US11723917B2 (en) Compositions of nitrates and methods of use thereof
Moreira et al. Pink pressure: beetroot (Beta vulgaris rubra) as a possible novel medical therapy for chronic kidney disease
US7629329B2 (en) Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20240226077A1 (en) Compositions and Methods for Increasing Athletic Performance
US20240285678A1 (en) Compositions of nitrates and methods of use thereof
US10835555B2 (en) Compositions of nitrates and methods of use thereof
Beręsewicz et al. Enjoy your heart-beets. The role of dietary inorganic nitrate in cardiovascular health
Ross Acute Effects of New Zealand Blackcurrant Extract on Exercise Performance: Implications of the Dose-Response Relationship and Use Under Simulated Altitude
JP2009263337A (ja) 抗疲労剤
JP2004105004A (ja) 食品組成物